These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30487080)

  • 21. From gut to lung and back again: early life microbiota in cystic fibrosis.
    Caverly LJ; Ross BD; Dickson RP
    Eur Respir J; 2024 May; 63(5):. PubMed ID: 38724179
    [No Abstract]   [Full Text] [Related]  

  • 22. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.
    Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY
    Sci Rep; 2016 May; 6():24857. PubMed ID: 27143104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Lung Microbiome and Airway Disease.
    Lynch SV
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 2(Suppl 5):S462-S465. PubMed ID: 28005424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the microbiome for human health: from basic science to clinical applications.
    Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
    Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Green H; Jones AM
    Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between Flavonoid Intakes and Gut Microbiota in a Group of Adults with Cystic Fibrosis.
    Li L; Somerset S
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30205496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?
    Rogers GB; Bruce KD; Hoffman LR
    Curr Opin Pulm Med; 2017 Nov; 23(6):536-543. PubMed ID: 28786882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation.
    Kirst ME; Baker D; Li E; Abu-Hasan M; Wang GP
    PLoS One; 2019; 14(9):e0222323. PubMed ID: 31536536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing?
    Whelan FJ; Surette MG
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S207-11. PubMed ID: 26595741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophilic proteolysis in the cystic fibrosis lung correlates with a pathogenic microbiome.
    Quinn RA; Adem S; Mills RH; Comstock W; DeRight Goldasich L; Humphrey G; Aksenov AA; Melnik AV; da Silva R; Ackermann G; Bandeira N; Gonzalez DJ; Conrad D; O'Donoghue AJ; Knight R; Dorrestein PC
    Microbiome; 2019 Feb; 7(1):23. PubMed ID: 30760325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
    Garg M; Ooi CY
    Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic but not intermittent infection with
    Boutin S; Graeber SY; Stahl M; Dittrich AS; Mall MA; Dalpke AH
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 28982777
    [No Abstract]   [Full Text] [Related]  

  • 34. Highlights from the 2019 North American Cystic Fibrosis Conference.
    Hoppe JE; Guimbellot J; Martiniano SL; Toprak D; Davis C; Daines CL; Muhlebach MS; Esther CR; Dellon EP
    Pediatr Pulmonol; 2020 Sep; 55(9):2225-2232. PubMed ID: 32573948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.
    Caverly LJ; LiPuma JJ
    Expert Rev Respir Med; 2018 Oct; 12(10):857-865. PubMed ID: 30118374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis.
    Hoen AG; Li J; Moulton LA; O'Toole GA; Housman ML; Koestler DC; Guill MF; Moore JH; Hibberd PL; Morrison HG; Sogin ML; Karagas MR; Madan JC
    J Pediatr; 2015 Jul; 167(1):138-47.e1-3. PubMed ID: 25818499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration.
    Bevivino A; Bacci G; Drevinek P; Nelson MT; Hoffman L; Mengoni A
    Trends Mol Med; 2019 Dec; 25(12):1110-1122. PubMed ID: 31439509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
    Kanhere M; He J; Chassaing B; Ziegler TR; Alvarez JA; Ivie EA; Hao L; Hanfelt J; Gewirtz AT; Tangpricha V
    J Clin Endocrinol Metab; 2018 Feb; 103(2):564-574. PubMed ID: 29161417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.